Sanjiu Investment To Acquire China Resources Dong E E Jiao
This article was originally published in PharmAsia News
Executive Summary
In its ambition to forge a centralized pharmaceutical platform, state-owned China Resources National Corp. has transferred its 56.619 percent stake in China Resources Dong E E Jiao to New Sanjiu Holding's investment management arm. In return, CRNC will acquire the equities of Sanjiu Enterprise Group from the holding company. Industry analysts observe that the move is not consistent with CRNC's original plan of operating Sanjiu's pharmaceutical business and Dong E E Jiao's health care products separately. However, with Dong E E Jiao now under New Sanjiu, it appears that CRNC intends to reorganize its strategy by integrating both businesses. (Click here for more - Chinese Language)